Citations (166)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jing Wang, Christian Karime, Umair Majeed, Jason S. Starr, Mitesh J. Borad & Hani M. Babiker. (2023) Targeting leukemia inhibitory factor in pancreatic adenocarcinoma. Expert Opinion on Investigational Drugs 32:5, pages 387-399.
Read now
Read now
Snehal Pardeshi, Amrendra Tiwari, Uday Titame, Pankaj K Singh, Pavan Kumar Yadav & Manish K. Chourasia. (2022) Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy. Journal of Liposome Research 32:4, pages 386-395.
Read now
Read now
Archana Thakur, Johnson Ung, Elyse N. Tomaszewski, Amy Schienschang, Timothy M. LaBrie, Dana L. Schalk & Lawrence G. Lum. (2021) Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. OncoImmunology 10:1.
Read now
Read now
Sheng-Chun Dang, Xiao-Bao Qian, Wei Jin, Lei Cui, Ji-Xiang Chen & Min Gu. (2019) G-protein-signaling modulator 2 expression and role in a CD133+ pancreatic cancer stem cell subset. OncoTargets and Therapy 12, pages 785-794.
Read now
Read now
Ling Ma, Jia Wei, Gloria H. Su & Jiayuh Lin. (2019) Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells. Cancer Biology & Therapy 20:6, pages 855-865.
Read now
Read now
Zhe Chen, Yuanqiang Zheng, Yanchun Shi & Zhengrong Cui. (2018) Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles. International Journal of Nanomedicine 13, pages 319-336.
Read now
Read now
Yanyan Hu, Erpeng Qi, Fangyi Liu, Yuhan Lu, Shuilian Tan, Ya Sun, Zhiyu Han, Ping Liang & Xiaoling Yu. (2018) The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer. OncoTargets and Therapy 11, pages 619-627.
Read now
Read now
Xuemeng Xie, Jinfu Tu, Heyi You & Bingren Hu. (2017) Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer. Drug Design, Development and Therapy 11, pages 1439-1451.
Read now
Read now
Sumit Arora, Suresh K Swaminathan, Ameya Kirtane, Sanjeev K Srivastava, Arun Bhardwaj, Seema Singh, Jayanth Panyam & Ajay P Singh. (2014) Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine 9, pages 2933-2942.
Read now
Read now
xiaobo cui, Yuqing Zhang, Jingxuan Yang, Xiaotian Sun, John Hagan, Sushovan Guha & Min Li. (2014) ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle 13:7, pages 1180-1186.
Read now
Read now
Frederik Köpper, Anna Maria Binkowski, Cathrin Bierwirth & Matthias Dobbelstein. (2014) The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells. Cell Cycle 13:6, pages 884-889.
Read now
Read now
Rahma Warsame & Axel Grothey. (2012) Treatment options for advanced pancreatic cancer: a review. Expert Review of Anticancer Therapy 12:10, pages 1327-1336.
Read now
Read now
Piyanuch Wonganan, Woon-Gye Chung, Saijie Zhu, Kaoru Kiguchi, John DiGiovanni & Zhengrong Cui. (2012) Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells. Cancer Biology & Therapy 13:10, pages 908-914.
Read now
Read now
Swapna Asuthkar, Jasti S Rao & Christopher S Gondi. (2012) Drugs in preclinical and early-stage clinical development for pancreatic cancer. Expert Opinion on Investigational Drugs 21:2, pages 143-152.
Read now
Read now
Articles from other publishers (152)
Farrukh Afaq, Sumit Agarwal, Prachi Bajpai, Sameer Al Diffalha, Hyung-Gyoon Kim, Shajan Peter, Moh'd Khushman, Subhash C Chauhan, Priyabrata Mukherjee, Sooryanarayana Varambally & Upender Manne. (2024) Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. Neoplasia 47, pages 100951.
Crossref
Crossref
Shwetapadma Dash, Sonali Sahoo & Sanjeeb Kumar Sahoo. 2024. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy
37
71
.
Zahra Asadzadeh, Nima Hemmat, Hamidreza Hassanian, Nazila Alizadeh, Ahad Mokhtarzadeh, Mahdi Jafarlou & Behzad Baradaran. (2023) Unraveling Dedifferentiation and Metastasis Traces in Pancreatic Ductal Adenocarcinoma Ductal Cells: Insights from Single-Cell RNA Sequencing Analysis of ITGB4 and C19orf33. Pathology - Research and Practice, pages 155012.
Crossref
Crossref
Xianfeng Wang, Zheng Chen, Dingrui Nie, Xiangbo Zeng, Mengjun Zhong, Xin Liu, Shuxin Zhong, Liang Wang, Ziwei Liao, Cunte Chen, Yangqiu Li & Chengwu Zeng. (2023) CASP1 is a target for combination therapy in pancreatic cancer. European Journal of Pharmacology 961, pages 176175.
Crossref
Crossref
Ruiqi Liu, Jiajun Wu, Haiwei Guo, Weiping Yao, Shuang Li, Yanwei Lu, Yongshi Jia, Xiaodong Liang, Jianming Tang & Haibo Zhang. (2023) Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 4:3.
Crossref
Crossref
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Hisayuki Amano, Masahiko Honda, Masahito Kawazu & Hitoshi Okada. (2023) MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance. Molecular Cancer Research 21:5, pages 444-457.
Crossref
Crossref
Chao Xu, Qinwen Ye, Chao Ye & Shaojun Liu. (2023) circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathway. Biology Direct 18:1.
Crossref
Crossref
Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, Enzhi Luo, Yeabeen Kim, Yulseung Sung, Ya Chun Yu, Kibum Kim, Do Sik Min, Hee Seung Lee, Geum-Sook Hwang, TaeJin Ahn, Junjeong Choi, Seungmin Bang & Jung Min Han. (2023) Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer. Cancer Research 83:5, pages 735-752.
Crossref
Crossref
Scott Widmann, Shivangi Srivastava & Chin-Yo Lin. (2023) A Novel Liver X Receptor Inverse Agonist Impairs Cholesterol and Phospholipid Metabolism and Induces Apoptosis and Necroptosis in Pancreatic Ductal Adenocarcinoma Cells. Receptors 2:1, pages 34-46.
Crossref
Crossref
Ignace Vergote, Teresa Macarulla, Fred R. Hirsch, Carsten Hagemann & David Scott Miller. (2023) Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment. Cancers 15:3, pages 636.
Crossref
Crossref
Wojciech Szlasa, Olga Michel, Natalia Sauer, Vitalij Novickij, Damian Lewandowski, Paulina Kasperkiewicz, Mounir Tarek, Jolanta Saczko & Julita Kulbacka. (2023) Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer. Scientific Reports 13:1.
Crossref
Crossref
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, Swathi Suresh, Basabi Rana & Ajay Rana. 2023. Pancreatic Cancer: Basic Mechanisms and Therapies. Pancreatic Cancer: Basic Mechanisms and Therapies
113
143
.
Madhuri Dutta, Debasish Mohapatra, Amlan Priyadarshee Mohapatra, Shantibhusan Senapati & Anasuya Roychowdhury. (2022) ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells. Biochemical and Biophysical Research Communications 635, pages 179-186.
Crossref
Crossref
Olga Michel, Wojciech Szlasa, Dagmara Baczyńska, Jolanta Saczko, Mounir Tarek & Julita Kulbacka. (2022) The role of catechin in electroporation of pancreatic cancer cells – Effects on pore formation and multidrug resistance proteins. Bioelectrochemistry 147, pages 108199.
Crossref
Crossref
Aida Šermukšnytė, Kristina Kantminienė, Ilona Jonuškienė, Ingrida Tumosienė & Vilma Petrikaitė. (2022) The Effect of 1,2,4-Triazole-3-thiol Derivatives Bearing Hydrazone Moiety on Cancer Cell Migration and Growth of Melanoma, Breast, and Pancreatic Cancer Spheroids. Pharmaceuticals 15:8, pages 1026.
Crossref
Crossref
Yangyang Ma, Yanli Xing, Hongmei Li, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Mao Lin & Lizhi Niu. (2022) Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Journal of Oncology 2022, pages 1-12.
Crossref
Crossref
Sarah E. Huff, Jordan M. Winter & Chris G. Dealwis. (2022) Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present. Biomolecules 12:6, pages 815.
Crossref
Crossref
Manjul Rana, Rita Kansal, Mehdi Chaib, Bin Teng, Michelle Morrrison, David Neil Hayes, Ansley G. Stanfill, David Shibata, James A. Carson, Liza Makowski & Evan S. Glazer. (2022) The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells. Molecular Carcinogenesis 61:6, pages 549-557.
Crossref
Crossref
María Cecilia Sanmartin, Francisco Raúl Borzone, María Belén Giorello, Gustavo Yannarelli & Norma Alejandra Chasseing. (2022) Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Yongsheng Ruan, Libai Chen, Danfeng Xie, Tingting Luo, Yiqi Xu, Tao Ye, Xiaona Chen, Xiaoqin Feng & Xuedong Wu. (2022) Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook. Frontiers in Endocrinology 13.
Crossref
Crossref
Anastasia L. Berg, Ashley Rowson-Hodel, Michelle Hu, Michael Keeling, Hao Wu, Kacey VanderVorst, Jenny J. Chen, Jason Hatakeyama, Joseph Jilek, Courtney A. Dreyer, Madelyn R. Wheeler, Ai-Ming Yu, Yuanpei Li & Kermit L. CarrawayIIIIII. (2022) The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies. Cancers 14:4, pages 949.
Crossref
Crossref
Tomas Koltai & Larry Fliegel. (2022) Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. Journal of Evidence-Based Integrative Medicine 27, pages 2515690X2110688.
Crossref
Crossref
Ying-Fang Fan, Wen-Ting Shang, Guan-Hua Lu, Kun-Xiong Guo, Han Deng, Xin-Hong Zhu, Cun-Chuan Wang & Jie Tian. (2021) Decreasing hyaluronic acid combined with drug-loaded nanoprobes improve the delivery and efficacy of chemotherapeutic drugs for pancreatic cancer. Cancer Letters 523, pages 1-9.
Crossref
Crossref
Barbara Wójcik, Ewa Sawosz, Jarosław Szczepaniak, Barbara Strojny, Malwina Sosnowska, Karolina Daniluk, Marlena Zielińska-Górska, Jaśmina Bałaban, André Chwalibog & Mateusz Wierzbicki. (2021) Effects of Metallic and Carbon-Based Nanomaterials on Human Pancreatic Cancer Cell Lines AsPC-1 and BxPC-3. International Journal of Molecular Sciences 22:22, pages 12100.
Crossref
Crossref
Fleur van der Sijde, Marjolein Y. V. Homs, Marlies L. van Bekkum, Thierry P. P. van den Bosch, Koop Bosscha, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Thomas M. Karsten, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Saskia A. C. Luelmo, Leonie J. M. Mekenkamp, Dana A. M. Mustafa, Johanna W. Wilmink, Casper H. J. van Eijck & Eveline E. Vietsch. (2021) Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study. International Journal of Molecular Sciences 22:20, pages 10902.
Crossref
Crossref
Huapeng Sun, Na Zhang, Yiqiang Jin & Haisheng Xu. (2021) Cardamonin Promotes the Apoptosis and Chemotherapy Sensitivity to Gemcitabine of Pancreatic Cancer Through Modulating the FOXO3a-FOXM1 Axis. Dose-Response 19:4, pages 155932582110421.
Crossref
Crossref
Heidi E. Roth, Fatema Bhinderwala, Rodrigo Franco, You Zhou & Robert Powers. (2021) DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma. Journal of Proteome Research 20:8, pages 3925-3939.
Crossref
Crossref
Anna J. Boland, Anthony A. O’Kane, Richard Buick, Daniel B. Longley & Christopher J. Scott. (2021) Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188557.
Crossref
Crossref
Katarzyna Ratajczak & Sylwia Borska. (2021) Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers. Molecules 26:14, pages 4350.
Crossref
Crossref
Zohreh Yaghobi, Aliakbar Movassaghpour, Mehdi Talebi, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Shiva Pourvahdani & Behzad Baradaran. (2021) The role of CD44 in cancer chemoresistance: A concise review. European Journal of Pharmacology 903, pages 174147.
Crossref
Crossref
Aydar Khabipov, Eric Freund, Kim Rouven Liedtke, Andre Käding, Janik Riese, Julia van der Linde, Stephan Kersting, Lars-Ivo Partecke & Sander Bekeschus. (2021) Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells. Cancers 13:11, pages 2525.
Crossref
Crossref
Young Eun Kim, Eun-Kyung Kim, Min-Jeong Song, Tae-Young Kim, Ho Hee Jang & Dukjin Kang. (2021) SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells. Cancers 13:4, pages 724.
Crossref
Crossref
Vimal Arora, Dinesh Kumar Chellappan, Krishnan Anand & Harish Dureja. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
243
257
.
Seung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, Soo-A Jung, Dong-In Koh, Yeaseong Ryu, Yoon Sun Park, Do Yeon Kim, Sang-Soo Park, Jun Ki Hong, Eun Ho Kim, Mi Jin Kim, Hong-Rae Jeong, In Hwan Bae, Young-Gil Ahn, Kwee Hyun Suh, Ig-Jun Cho, Jong-Soon Kang, Yong Sang Hong, Jung Shin Lee, Dong-Hoon Jin & Tae Won Kim. (2020) Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells. Investigational New Drugs 38:6, pages 1696-1706.
Crossref
Crossref
Parisa Norouzi, Mohsen Amini, Rassoul Dinarvand, Ehsan Arefian, Ehsan Seyedjafari & Fatemeh Atyabi. (2020) Co-delivery of gemcitabine prodrug along with anti NF-κB siRNA by tri-layer micelles can increase cytotoxicity, uptake and accumulation of the system in the cancers. Materials Science and Engineering: C 116, pages 111161.
Crossref
Crossref
Milad Ashrafizadeh, Mohammad Reza Bakhoda, Zahra Bahmanpour, Khandan Ilkhani, Ali Zarrabi, Pooyan Makvandi, Haroon Khan, Samaneh Mazaheri, Maryam Darvish & Hamed Mirzaei. (2020) Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry 8.
Crossref
Crossref
Bao Chen Yang & Po Sing Leung. (2020) Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer. Molecular Therapy - Oncolytics 18, pages 457-466.
Crossref
Crossref
Aki Kohyama, Rei Yokoyama, Dya Fita Dibwe, Sahar El-Mekkawy, Meselhy R. Meselhy, Suresh Awale & Yuji Matsuya. (2020) Synthesis of guggulsterone derivatives as potential anti-austerity agents against PANC-1 human pancreatic cancer cells. Bioorganic & Medicinal Chemistry Letters 30:7, pages 126964.
Crossref
Crossref
Melis Debreli Coskun, Thangirala Sudha, Dhruba J. Bharali, Serap Celikler, Paul J. Davis & Shaker A. Mousa. (2020) αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model. Frontiers in Pharmacology 11.
Crossref
Crossref
Rongkun Li, Li Weng, Bingyan Liu, Lili Zhu, Xiaoxin Zhang, Guangang Tian, Lipeng Hu, Qing Li, Shuheng Jiang & Mingyi Shang. (2019) TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR‐glycolysis signaling axis. Journal of Cellular Biochemistry 121:2, pages 1986-1997.
Crossref
Crossref
Neeraj Chauhan, Amber Kruse, Hilary Newby, Meena Jaggi, Murali M. Yallapu & Subhash C. Chauhan. (2020) Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. ACS Omega 5:2, pages 1147-1156.
Crossref
Crossref
Zhong Hong, Zhaohong Wang, Bin Zhou, Jisheng Wang, Hongfei Tong, Yi Liao, Peng Zheng, Muhammad Jamshed, Qiyu Zhang & Hui Chen. (2020) Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. International Journal of Oncology.
Crossref
Crossref
Mohammed Sikander, Shabnam Malik, Sheema Khan, Sonam Kumari, Neeraj Chauhan, Parvez Khan, Fathi T. Halaweish, Bhavin Chauhan, Murali M. Yallapu, Meena Jaggi & Subhash C. Chauhan. (2019) Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells 9:1, pages 103.
Crossref
Crossref
Chen-Yu Hu, Xiang-Ming Xu, Bo Hong, Zhi-Gang Wu, Yun Qian, Tian-Hao Weng, Yi-Zhi Liu, Tao-Ming Tang, Ming-Hai Wang & Hang-Ping Yao. (2019) Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Yang Zhou, Yunjiang Zhou, Keke Wang, Tao Li, Minda Zhang, Yunjia Yang, Rui Wang & Rong Hu. (2019) ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. Cancers 11:12, pages 1881.
Crossref
Crossref
Ling Yang, Xiaoting Sun, Ying Ye, Yongtian Lu, Ji Zuo, Wen Liu, Adrian Elcock & Shun Zhu. (2019) p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. Frontiers in Oncology 9.
Crossref
Crossref
Dieudonné Tshitenge Tshitenge, Torsten Bruhn, Doris Feineis, David Schmidt, Virima Mudogo, Marcel Kaiser, Reto Brun, Frank Würthner, Suresh Awale & Gerhard Bringmann. (2019)
Ealamines A–H, a Series of Naphthylisoquinolines with the Rare 7,8′-Coupling Site, from the Congolese Liana
Ancistrocladus ealaensis
, Targeting Pancreatic Cancer Cells
. Journal of Natural Products 82:11, pages 3150-3164.
Crossref
Crossref
Qi Chen, Jianxin Wang, Qi Zhang, Jingying Zhang, Yu Lou, Jiaqi Yang, Yiwen Chen, Tao Wei, Jian Zhang, Qihan Fu, Mao Ye, Xiaozhen Zhang, Xiaowei Dang, Tingbo Liang & Xueli Bai. (2019) Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages. British Journal of Cancer 121:9, pages 786-795.
Crossref
Crossref
Qian, Xiong, Feng, Wu, Zhang, Chen & Gu. (2019) Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study. International Journal of Molecular Sciences 20:21, pages 5250.
Crossref
Crossref
Yue Yu, Fei Ding, Meng Gao, Yi Jia & Le Ren. (2019) Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabine. Oncology Letters.
Crossref
Crossref
Alejandro Carozzo, Agustín Yaneff, Natalia Gómez, Nicolás Di Siervi, Ana Sahores, Federico Diez, Alejandra I. Attorresi, Ángela Rodríguez-González, Federico Monczor, Natalia Fernández, Martín Abba, Carina Shayo & Carlos Davio. (2019) Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. Molecular Pharmacology 96:1, pages 13-25.
Crossref
Crossref
Mingtan Tang, Darren Svirskis, Euphemia Leung, Manju Kanamala, Hongbo Wang & Zimei Wu. (2019) Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?. Journal of Controlled Release 305, pages 89-100.
Crossref
Crossref
Ivana Štaka, Ana Cadete, Bhanu Teja Surikutchi, Haneen Abuzaid, Tracey D. Bradshaw, Maria J. Alonso & Maria Marlow. (2019) A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs. International Journal of Pharmaceutics 565, pages 151-161.
Crossref
Crossref
Jungwhoi Lee, Da-Hye Kim & Jae Hoon Kim. (2019) Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway. Phytomedicine 58, pages 152762.
Crossref
Crossref
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, Denis Pezet, Gael Deplanque, Martin Fuchs, Jorg Trojan, Mark Kozloff, Francesca Simionato, Ann Cleverly, Claire Smith, Shuaicheng Wang, Michael Man, Kyla E. Driscoll, Shawn T. Estrem, Michael M. F. Lahn, Karim A. Benhadji & Josep Tabernero. (2019) TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer. Cancer Chemotherapy and Pharmacology 83:5, pages 975-991.
Crossref
Crossref
Weijing Cai, Ranjala Ratnayake, Michael H. Gerber, Qi-Yin Chen, Yichao Yu, Hartmut Derendorf, Jose G. Trevino & Hendrik Luesch. (2018) Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Investigational New Drugs 37:2, pages 364-374.
Crossref
Crossref
Guan-Hua Lu, Wen-Ting Shang, Han Deng, Zi-Yu Han, Min Hu, Xiao-Yuan Liang, Chi-Hua Fang, Xin-Hong Zhu, Ying-Fang Fan & Jie Tian. (2019) Targeting carbon nanotubes based on IGF-1R for photothermal therapy of orthotopic pancreatic cancer guided by optical imaging. Biomaterials 195, pages 13-22.
Crossref
Crossref
Aesha I. Ali, Amanda J. Oliver, Tinaz Samiei, Jack D. Chan, Michael H. Kershaw & Clare Y. Slaney. (2019) Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Chetan K. Rane & Audrey Minden. (2019) P21 activated kinase signaling in cancer. Seminars in Cancer Biology 54, pages 40-49.
Crossref
Crossref
Melanie Predebon, Danielle Bond, Joshua Brzozowski, Helen Jankowski, Fiona Deane, Mark Tarleton, Aron Shaw, Adam McCluskey, Michael Bowyer, Judith Weidenhofer & Christopher Scarlett. (2019) The Bispidinone Derivative 3,7-Bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one Dihydrochloride Induces an Apoptosis-Mediated Cytotoxic Effect on Pancreatic Cancer Cells In Vitro. Molecules 24:3, pages 524.
Crossref
Crossref
Hao Cheng, Hao Zhu, Meng Cao, Chenglin Lu, Shanhua Bao & Yiming Pan. (2019) HtrA1 suppresses the growth of pancreatic cancer cells by modulating Notch-1 expression. Brazilian Journal of Medical and Biological Research 52:1.
Crossref
Crossref
Sneha Govardhanagiri, Shipra Bethi & Ganji Purnachandra Nagaraju. 2019. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy
117
131
.
Suresh Chava, Meher B. Gayatri & Aramati B.M. Reddy. 2019. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy
25
43
.
Xiang Ling, Wenjie Wu, Chuandong Fan, Chao Xu, Jianqun Liao, Laurie J. Rich, Ruea-Yea Huang, Elizabeth A. Repasky, Xinjiang Wang & Fengzhi Li. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Azeez A. Fatai & Junaid Gamieldien. (2018) A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. BMC Cancer 18:1.
Crossref
Crossref
Baharak Bahmani, Mayuko Uehara, Farideh Ordikhani, Xiaofei Li, Liwei Jiang, Naima Banouni, Takaharu Ichimura, Vivek Kasinath, Siawosh K. Eskandari, Nasim Annabi, Jonathan S. Bromberg, Leonard D. Shultz, Dale L. Greiner & Reza Abdi. (2018) Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery. eBioMedicine 38, pages 79-88.
Crossref
Crossref
Suresh Awale, Dya Fita Dibwe, Chandrasekar Balachandran, Shaimaa Fayez, Doris Feineis, Blaise Kimbadi Lombe & Gerhard Bringmann. (2018)
Ancistrolikokine E
3
, a 5,8′-Coupled Naphthylisoquinoline Alkaloid, Eliminates the Tolerance of Cancer Cells to Nutrition Starvation by Inhibition of the Akt/mTOR/Autophagy Signaling Pathway
. Journal of Natural Products 81:10, pages 2282-2291.
Crossref
Crossref
Deepanshi Dhar, Gagan Deep, Sushil Kumar, Michael F. Wempe, Komal Raina, Chapla Agarwal & Rajesh Agarwal. (2018) Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Molecular Carcinogenesis 57:9, pages 1166-1180.
Crossref
Crossref
Sachin Kumar Deshmukh, Nikhil Tyagi, Mohammad Aslam Khan, Sanjeev Kumar Srivastava, Ahmed Al-Ghadhban, Kari Dugger, James Elliot Carter, Seema Singh & Ajay Pratap Singh. (2018) Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages. Scientific Reports 8:1.
Crossref
Crossref
Chao-yuan Tang, Li-xin Zhu, Jian-dong Yu, Zhi Chen, Man-cang Gu, Chao-feng Mu, Qi Liu & Yang Xiong. (2018) Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism. European Journal of Pharmaceutical Sciences 120, pages 20-29.
Crossref
Crossref
Catherine B. MarElia, Arielle E. Sharp, Tiffany A. Shemwell, Y. Clare Zhang & Brant R. Burkhardt. (2018)
Anemarrhena asphodeloides
Bunge and its constituent timosaponin‐
AIII
induce cell cycle arrest and apoptosis in pancreatic cancer cells
. FEBS Open Bio 8:7, pages 1155-1166.
Crossref
Crossref
Lian-Yu Chen, Chien-Shan Cheng, Chao Qu, Peng Wang, Hao Chen, Zhi-Qiang Meng & Zhen Chen. (2018) Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression. International Journal of Molecular Sciences 19:6, pages 1768.
Crossref
Crossref
L. Li, S.L. Zhao, G.G.L. Yue, T.P. Wong, J.X. Pu, H.D. Sun, K.P. Fung, P.C. Leung, Q.B. Han, C.B.S. Lau & P.S. Leung. (2018) Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer. Phytomedicine 44, pages 56-64.
Crossref
Crossref
Aleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, Minkyoung Kim, Norbaini Binti Abdol Razak, Pat Metharom & Marco Falasca. (2018) Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Advances in Biological Regulation 68, pages 77-87.
Crossref
Crossref
Adriana Harbuzariu & Ruben Rene Gonzalez-Perez. (2018) Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer. Oncotarget 9:26, pages 18239-18253.
Crossref
Crossref
John Nebu, J.S. Anjali Devi, R.S. Aparna, K. Abha & George Sony. (2018) Erlotinib conjugated gold nanocluster enveloped magnetic iron oxide nanoparticles–A targeted probe for imaging pancreatic cancer cells. Sensors and Actuators B: Chemical 257, pages 1035-1043.
Crossref
Crossref
Miriam Widder, Karen Lemke, Bünyamin Kekeç, Tobias Förster, Andreas Grodrian & Gunter Gastrock. (2018) A modified 384-well-device for versatile use in 3D cancer cell (co-)cultivation and screening for investigations of tumor biology in vitro. Engineering in Life Sciences 18:2, pages 132-139.
Crossref
Crossref
Irene S. Yu & Winson Y. Cheung. (2018) A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-10.
Crossref
Crossref
Susumu Ishiguro, Atsushi Kawabata, Alejandro Zulbaran-Rojas, Kelsey Monson, Deepthi Uppalapati, Naomi Ohta, Makoto Inui, Charalampos G. Pappas, Andreas G. Tzakos & Masaaki Tamura. (2018) Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation. Biochemical and Biophysical Research Communications 495:1, pages 962-968.
Crossref
Crossref
Rebecca A. Richmond, Quan V. Vuong & Christopher J. Scarlett. (2017) Cytotoxic Effect of Bitter Melon (Momordica charantia L.) Ethanol Extract and Its Fractions on Pancreatic Cancer Cells in vitro. Exploratory Research and Hypothesis in Medicine 2:4, pages 1-11.
Crossref
Crossref
Susanna W. L. de Geus, Mariam F. Eskander, Gyulnara G. Kasumova, Sing Chau Ng, Tara S. Kent, Joseph D. Mancias, Mark P. Callery, Anand Mahadevan & Jennifer F. Tseng. (2017) Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Cancer 123:21, pages 4158-4167.
Crossref
Crossref
Jair Machado Espindola-Netto, Claudia C.S. Chini, Mariana Tarragó, Enfeng Wang, Shamit Dutta, Krishnendu Pal, Debabrata Mukhopadhyay, Mauro Sola-Penna & Eduardo N. Chini. (2017) Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer. Oncotarget 8:49, pages 85054-85067.
Crossref
Crossref
Azam Rajabpour, Ali Afgar, Habibollah Mahmoodzadeh, Jalal-e-Din Radfar, Farzad Rajaei & Ladan Teimoori-Toolabi. (2017) MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology 80:4, pages 765-775.
Crossref
Crossref
Richard Sleightholm, Bin Yang, Fei Yu, Ying Xie & David Oupický. (2017) Chloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy. Biomacromolecules 18:8, pages 2247-2257.
Crossref
Crossref
Xiangxuan Zhao, Wei Sun, William M Puszyk, Shannon Wallet, Steve Hochwald, Keith Robertson & Chen Liu. (2017) Focal adhesion kinase inhibitor PF573228 and death receptor 5 agonist lexatumumab synergistically induce apoptosis in pancreatic carcinoma. Tumor Biology 39:5, pages 101042831769912.
Crossref
Crossref
M. E. Hubbard, M. Jove, P. M. Loadman, R. M. Phillips, C. J. Twelves & S. W. Smye. (2017) Drug delivery in a tumour cord model: a computational simulation. Royal Society Open Science 4:5, pages 170014.
Crossref
Crossref
Dannel Yeo, Phoebe Phillips, Graham S. Baldwin, Hong He & Mehrdad Nikfarjam. (2017) Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer. International Journal of Cancer 140:9, pages 2101-2111.
Crossref
Crossref
Vincent Hung-Shu Chang, Yi-Chih Tsai, Ya-Li Tsai, Shu-Ling Peng, Su-Liang Chen, Tsung Ming Chang, Winston Chun-Yuan Yu & Hui-Ju Ch'ang. (2017) Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene. Radiotherapy and Oncology 122:3, pages 476-484.
Crossref
Crossref
Azam Rajabpour, Farzad Rajaei & Ladan Teimoori-Toolabi. (2017) Molecular alterations contributing to pancreatic cancer chemoresistance. Pancreatology 17:2, pages 310-320.
Crossref
Crossref
Jungwhoi Lee, Jungsul Lee, Myungseung Kim & Jae Hoon Kim. (2017) Dietary approach to attenuate human pancreatic cancer growth and migration with innoxiousness. Journal of Functional Foods 30, pages 303-312.
Crossref
Crossref
Lei Zhu, Charles Staley, David Kooby, Bassel El-Rays, Hui Mao & Lily Yang. (2017) Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy. Cancer Letters 388, pages 139-148.
Crossref
Crossref
Vera Skripova, Ilya Serebriiskii, Zinaida Abramova, Igor Astsaturov & Ramziya Kiyamova. (2016) CRISPR/Cas9 Technique for Identification of Genes Regulating Oxaliplatin Resistance of Pancreatic Cancer Cell Line. BioNanoScience 7:1, pages 97-100.
Crossref
Crossref
Hao Cheng, Chenglin Lu, Ribo Tang, Yiming Pan, Shanhua Bao, Yudong Qiu & Min Xie. (2017)
Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells
in vitro
and
in vivo
. Oncotarget 8:7, pages 12301-12310.
Crossref
Crossref
Shaimaa Fayez, Doris Feineis, Virima Mudogo, Suresh Awale & Gerhard Bringmann. (2017)
Ancistrolikokines E–H and related 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese liana
Ancistrocladus likoko
with antiausterity activities against PANC-1 human pancreatic cancer cells
. RSC Advances 7:85, pages 53740-53751.
Crossref
Crossref
Lin Li & Po Sing Leung. 2017. Gastrointestinal Tissue. Gastrointestinal Tissue
173
186
.
Xia Liu, Xiang-yang Xiao, Qi-yang Shou, Jun-feng Yan, Long Chen, Hui-ying Fu & Jian-chao Wang. (2016) Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of Ethnopharmacology 193, pages 538-545.
Crossref
Crossref
Lijun Zhao, Dongling Zou, Xueju Wei, Lanlan Wang, Yuanyuan Zhang, Siqi Liu, Yanmin Si, Hualu Zhao, Fang Wang, Jia Yu, Yanni Ma & Guotao Sun. (2016) MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. Tumor Biology 37:12, pages 16053-16063.
Crossref
Crossref
Jason J. Kwon, Jeffrey A. Willy, Kayla A. Quirin, Ronald C. Wek, Murray Korc, Xiao-Ming Yin & Janaiah Kota. (2016) Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential. Oncotarget 7:44, pages 71635-71650.
Crossref
Crossref
Neal Bhutiani, Steven Agle, Yan Li, Suping Li & Robert C.G. MartinIIII. (2016) Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma. Journal of Surgical Oncology 114:2, pages 181-186.
Crossref
Crossref
Tao Yin, Zhengle Zhang, Bin Cao, Qingke Duan, Pengfei Shi, Hengqiang Zhao, Soriba Naby Camara, Qiang Shen & Chunyou Wang. (2016) Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine. Oncotarget 7:24, pages 37192-37204.
Crossref
Crossref
Jungwhoi Lee & Jae Hoon Kim. (2016) Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro. PLOS ONE 11:5, pages e0155264.
Crossref
Crossref
JUNRO KATAOKA, HIDENORI SHIRAHA, SHIGERU HORIGUCHI, HIROAKI SAWAHARA, DAISUKE UCHIDA, TERUYA NAGAHARA, MASAYA IWAMURO, HIROKI MORIMOTO, YASUTO TAKEUCHI, KENJI KUWAKI, HIDEKI ONISHI, SHINICHIRO NAKAMURA, AKINOBU TAKAKI, KAZUHIRO NOUSO, TAKAHITO YAGI, KAZUHIDE YAMAMOTO & HIROYUKI OKADA. (2016) Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. Oncology Reports 35:5, pages 2576-2582.
Crossref
Crossref
JUNGWHOI LEE, JUNGSUL LEE, SEUNG JUN KIM & JAE HOON KIM. (2016) Quercetin-3-O-glucoside suppresses pancreatic cancer cell migration induced by tumor-deteriorated growth factors in vitro. Oncology Reports 35:4, pages 2473-2479.
Crossref
Crossref
Yue Sun, Mancang Gu, Lixin Zhu, Junying Liu, Yang Xiong, Yinghui Wei & Fanzhu Li. (2016) Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of bioluminescence in pancreatic cancer cells. Anti-Cancer Drugs 27:3, pages 183-191.
Crossref
Crossref
Zhezhu Han, Seungha Lee, Suyeon Je, Chi-Yong Eom, Hye Jin Choi, Jae J. Song & Joo-Hang Kim. (2015) Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells. Apoptosis 21:3, pages 351-364.
Crossref
Crossref
Sivapriya Ponnurangam, Prasad R. Dandawate, Animesh Dhar, Ossama W. Tawfik, Rajashri R. Parab, Prabhu Dutt Mishra, Prafull Ranadive, Rajiv Sharma, Girish Mahajan, Shahid Umar, Scott J. Weir, Aravind Sugumar, Roy A. Jensen, Subhash B. Padhye, Arun Balakrishnan, Shrikant Anant & Dharmalingam Subramaniam. (2015) Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Oncotarget 7:3, pages 3217-3232.
Crossref
Crossref
Christopher G. England, Reinier Hernandez, Savo Bou Zein Eddine & Weibo Cai. (2015) Molecular Imaging of Pancreatic Cancer with Antibodies. Molecular Pharmaceutics 13:1, pages 8-24.
Crossref
Crossref
Carlos J. Díaz Osterman, Amber Gonda, TessaRae Stiff, Ulysses Sigaran, Malyn May Asuncion Valenzuela, Heather R. Ferguson Bennit, Ron B. Moyron, Salma Khan & Nathan R. Wall. (2016) Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis. Pancreas 45:1, pages 101-109.
Crossref
Crossref
Bi-Wen Yeh, Wei-Ming Li, Ching-Chia Li, Wan-Yi Kang, Chun-Nung Huang, Tzyh-Chyuan Hour, Zi-Miao Liu, Wen-Jeng Wu & Huei-Sheng Huang. (2016) Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor. Toxicology and Applied Pharmacology 290, pages 98-106.
Crossref
Crossref
Archana Bhaw-Luximon, Nowsheen Goonoo & Dhanjay Jhurry. 2016. Nanobiomaterials in Cancer Therapy. Nanobiomaterials in Cancer Therapy
147
201
.
Wenyuan Yin, Charles W. Kimbrough, Jorge G. Gomez-Gutierrez, Christopher T. Burns, Phillip Chuong, William E. Grizzle & Lacey R. McNally. (2015) Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. Journal of Nanobiotechnology 13:1.
Crossref
Crossref
Vikas Yadav, Pallavi Varshney, Sarwat Sultana, Jyoti Yadav & Neeru Saini. (2015) Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation. BMC Cancer 15:1.
Crossref
Crossref
Prashant Kesharwani, Lingxiao Xie, Sanjeev Banerjee, Guangzhao Mao, Subhash Padhye, Fazlul H. Sarkar & Arun K. Iyer. (2015) Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids and Surfaces B: Biointerfaces 136, pages 413-423.
Crossref
Crossref
A Borah, S Raveendran, A Rochani, T Maekawa & D S Kumar. (2015) Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis 4:11, pages e177-e177.
Crossref
Crossref
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand & Pascal Hammel. (2015) State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacology & Therapeutics 155, pages 80-104.
Crossref
Crossref
Xu Zhu, Robert M. Straubinger & William J. Jusko. (2015) Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells. Journal of Pharmacokinetics and Pharmacodynamics 42:5, pages 477-496.
Crossref
Crossref
Prashant Kesharwani, Sanjeev Banerjee, Subhash Padhye, Fazlul H. Sarkar & Arun K. Iyer. (2015) Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. Biomacromolecules 16:9, pages 3042-3053.
Crossref
Crossref
Sabiha Kazim, Mokenge P. Malafa, Domenico Coppola, Kazim Husain, Sherma Zibadi, Trinayan Kashyap, Marsha Crochiere, Yosef Landesman, Tami Rashal, Daniel M. Sullivan & Amit Mahipal. (2015) Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer. Molecular Cancer Therapeutics 14:7, pages 1570-1581.
Crossref
Crossref
Sheema Khan, Neeraj Chauhan, Murali M. Yallapu, Mara C. Ebeling, Swathi Balakrishna, Robert T. Ellis, Paul A. Thompson, Pavan Balabathula, Stephen W. Behrman, Nadeem Zafar, Man M. Singh, Fathi T. Halaweish, Meena Jaggi & Subhash C. Chauhan. (2015) Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials 53, pages 731-743.
Crossref
Crossref
Dongxu Kang, Hye Jin Choi, Sujin Kang, So Young Kim, Yong-sic Hwang, Suyeon Je, Zhezhu Han, Joo-Hang Kim & Jae J. Song. (2015) Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells. Cellular Signalling 27:4, pages 807-817.
Crossref
Crossref
JIAKE FENG, TIELIANG MA, ZHIJUN GE, JIE LIN, WEILIANG DING, HONG CHEN, WENJIAO ZHU, SUJUN ZHOU & YONGFEI TAN. (2015) PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways. Molecular Medicine Reports 11:3, pages 2111-2117.
Crossref
Crossref
Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Enrico N. De Toni, Burkhard Göke & Eike Gallmeier. (2014)
Overexpression of heat shock protein 27 (
HSP
27) increases gemcitabine sensitivity in pancreatic cancer cells through S‐phase arrest and apoptosis
. Journal of Cellular and Molecular Medicine 19:2, pages 340-350.
Crossref
Crossref
Eric Romney & Vinay J. Nagaraj. (2015) <i>In Vitro</i> Model Systems to Investigate Drug Resistance Mechanisms in Pancreatic Cancer Cells. Advances in Biological Chemistry 05:07, pages 286-292.
Crossref
Crossref
Fei Chen, Yang Guo & Liangjing Wang. (2015) The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer. Gastrointestinal Tumors 2:3, pages 131-143.
Crossref
Crossref
Jodee L. Johnson, Vermont P. Dia, Matthew Wallig & Elvira Gonzalez de Mejia. (2015) Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model. Pancreas 44:1, pages 144-151.
Crossref
Crossref
Evandro Luís Niero, Bianca Rocha-Sales, Camila Lauand, Beatriz Araujo Cortez, Marcelo Medina de Souza, Paula Rezende-Teixeira, Marcel Shiniti Urabayashi, Adam Arai Martens, Jorge Henrique Neves & Gláucia Maria Machado-Santelli. (2014) The multiple facets of drug resistance: one history, different approaches. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Crossref
Catherine Burkhart, Daria Fleyshman, Rachael Kohrn, Mairead Commane, Jennifer Garrigan, Vadim Kurbatov, Ilya Toshkov, Rajesh Ramachandran, Laura Martello & Katerina V. Gurova. (2014) Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget 5:22, pages 11038-11053.
Crossref
Crossref
BENQUAN WANG, QIAN ZOU, MENG SUN, JINGFENG CHEN, TIANYANG WANG, YONGHENG BAI, ZONGJING CHEN, BICHENG CHEN & MENGTAO ZHOU. (2014) Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. Oncology Reports 32:5, pages 2015-2022.
Crossref
Crossref
Sheema Khan, Mara C. Ebeling, Mohd S. Zaman, Mohammed Sikander, Murali M. Yallapu, Neeraj Chauhan, Ashley M. Yacoubian, Stephen W. Behrman, Nadeem Zafar, Deepak Kumar, Paul A. Thompson, Meena Jaggi & Subhash C. Chauhan. (2014) MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget 5:17, pages 7599-7609.
Crossref
Crossref
Lin Li & Po Sing Leung. (2014) Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer. The International Journal of Biochemistry & Cell Biology 53, pages 224-236.
Crossref
Crossref
HONG-QUAN DUONG, YONG WEON YI, HYO JIN KANG, INSOO BAE, YOUNG-JOO JANG, SAHNG-JUNE KWAK & YEON-SUN SEONG. (2014) Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells. International Journal of Oncology 44:6, pages 2132-2138.
Crossref
Crossref
Rahul Kumar, Kumardeep Chaudhary, Deepak Singla, Ankur Gautam & Gajendra P. S. Raghava. (2014) Designing of promiscuous inhibitors against pancreatic cancer cell lines. Scientific Reports 4:1.
Crossref
Crossref
A. Bhangu, G. Wood, G. Brown, A. Darzi, P. Tekkis & R. Goldin. (2014) The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer. Colorectal Disease 16:4, pages O133-O143.
Crossref
Crossref
C Güngör, B T Hofmann, G Wolters-Eisfeld & M Bockhorn. (2014) Pancreatic cancer. British Journal of Pharmacology 171:4, pages 849-858.
Crossref
Crossref
Cristiana Pistol Tanase. (2014) Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World Journal of Gastroenterology 20:31, pages 10790.
Crossref
Crossref
Xiao Du, Yu-pei Zhao, Tai-ping Zhang, Li Zhou, Ge Chen, Tian-xiao Wang, Lei You & Hong Shu. (2014) Alteration of the Intrinsic Apoptosis Pathway Is Involved in Notch-induced Chemoresistance to Gemcitabine in Pancreatic Cancer. Archives of Medical Research 45:1, pages 15-20.
Crossref
Crossref
María P. Torres, Satyanarayana Rachagani, Joshua J. Souchek, Kavita Mallya, Sonny L. Johansson & Surinder K. Batra. (2013) Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy. PLoS ONE 8:11, pages e80580.
Crossref
Crossref
Jodee L. Johnson & Elvira Gonzalez de Mejia. (2013) Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food and Chemical Toxicology 60, pages 83-91.
Crossref
Crossref
Sumit Arora, Arun Bhardwaj, Seema Singh, Sanjeev K. Srivastava, Steven McClellan, Chaitanya S. Nirodi, Gary A. Piazza, William E. Grizzle, Laurie B. Owen & Ajay P. Singh. (2013) An Undesired Effect of Chemotherapy. Journal of Biological Chemistry 288:29, pages 21197-21207.
Crossref
Crossref
Piyanuch Wonganan, Dharmika S.P. Lansakara-P, Saijie Zhu, Melisande Holzer, Michael A. Sandoval, Mangalika Warthaka & Zhengrong Cui. (2013) Just getting into cells is not enough: Mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression. Journal of Controlled Release 169:1-2, pages 17-27.
Crossref
Crossref
Shinichi Ota, Jean-Francois H. Geschwind, Manon Buijs, Joost W. Wijlemans, Byung Kook Kwak & Shanmugasundaram Ganapathy-Kanniappan. (2013) Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer. Targeted Oncology 8:2, pages 145-151.
Crossref
Crossref
Muxing Kang, Biao Jiang, Bin Xu, Wenjie Lu, Qingqu Guo, Qiuping Xie, Bo Zhang, Xin Dong, Daniel Chen & Yulian Wu. (2013) Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Cancer Letters 330:1, pages 11-21.
Crossref
Crossref
Gary Gellerman, Sophia Baskin, Luboshits Galia, Yosef Gilad & Michael A. Firer. (2013) Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide. Anti-Cancer Drugs 24:2, pages 112-119.
Crossref
Crossref
JIN-XIANG LIU, JIAN-HONG ZHANG, HONG-HAI LI, FU-JI LAI, KANG-JIE CHEN, HUI CHEN, JIANG LUO, HONG-CHUN GUO, ZHAO-HONG WANG & SHENG-ZHANG LIN. (2012) Emodin induces Panc-1 cell apoptosis via declining the mitochondrial membrane potential. Oncology Reports 28:6, pages 1991-1996.
Crossref
Crossref
Aneel Bhangu, Gemma Wood, Alex Mirnezami, Ara Darzi, Paris Tekkis & Robert Goldin. (2012) Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy. Surgical Oncology 21:4, pages 316-323.
Crossref
Crossref
Xiaoling Ni, Jingxuan Yang & Min Li. (2012) Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model. Cancer Letters 324:2, pages 179-185.
Crossref
Crossref
Gang Sun, Marlys A. Anderson, Emmanuel C. Gorospe, Cadman L. Leggett, Lori S. Lutzke, Louis M. Wong Kee Song, Michael Levy & Kenneth K. Wang. (2012) Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines. Lasers in Surgery and Medicine 44:9, pages 755-761.
Crossref
Crossref
John R. Hornick, Dirk Spitzer, Peter Goedegebuure, Robert H. Mach & William G. Hawkins. (2012) Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands. Surgery 152:3, pages S152-S156.
Crossref
Crossref
Xiaoling Ni, Jiang Long, Putao Cen, Leon Chen, Jingxuan Yang & Min Li. (2012) Pancreatic cancer tumour initiating cells: the molecular regulation and therapeutic values. Journal of Cellular and Molecular Medicine 16:5, pages 988-994.
Crossref
Crossref
Yong-Wei Wang, Shuang-Jia Wang, Yi-Nan Zhou, Shang-Ha Pan & Bei Sun. (2012) Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. Journal of Cancer Research and Clinical Oncology 138:5, pages 785-797.
Crossref
Crossref
Dong Chen, Min Niu, Xuelong Jiao, Kejun Zhang, Jun Liang & Dianliang Zhang. (2012) Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 13:1, pages 1186-1208.
Crossref
Crossref
Yi Xia, Palma Rocchi, Juan L. Iovanna & Ling Peng. (2012) Targeting heat shock response pathways to treat pancreatic cancer. Drug Discovery Today 17:1-2, pages 35-43.
Crossref
Crossref